文章：

ITGA2通过激活AKT/FOXO3A信号通路介导肝细胞癌对乐伐替尼的耐药性

ITGA2 Mediates the Resistance of Hepatocellular Carcinoma to Lenvatinib by Activating the AKT/FOXO3A Signaling Pathway

原文发布日期：29 August 2025

DOI: 10.3390/cancers17172846

类型: Article

开放获取: 是

英文摘要：

The global incidence of primary liver cancer ranks sixth among malignant tumors, while its mortality rate ranks third and is the second leading cause of cancer-related deaths in China [...]

摘要翻译： 

原发性肝癌的全球发病率在恶性肿瘤中位列第六，而其死亡率则高居第三位，是中国癌症相关死亡的第二大原因。

原文链接：

ITGA2 Mediates the Resistance of Hepatocellular Carcinoma to Lenvatinib by Activating the AKT/FOXO3A Signaling Pathway